Schering to Float Genomics Business in 2001 -Reuters

Sep 06, 2000

NEW YORK, Sept 6 - German pharmaceuticals group Schering AG intends to float its functional genomics biotech business next year, Reuters reported on Wednesday.

Schering said that the offering would take place after the company raises as much as $35 million in venture capital for the unit.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Cloud Ready

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

The Science and Policy Connection

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

The New Yeast

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

This Week in Cell

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.

Main menu